Generation Bio is developing a breakthrough class of genetic medicines based on its proprietary GeneWave technology Founded by Mark D. Angelino and Robert Kotin in 2016, Generation Bio is backed by investors that include T. Rowe Price, Deerfield, Foresite Capital, Atlas Venture, and Fidelity and is headquartered in Cambridge.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Genetics, Health Care
FOUNDERS:
Mark D. Angelino, Robert Kotin
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
